20 August 2018
Impact of Osteoporosis on the Risk of Dementia in Almost 60,000 Patients Followed in General Practices in Germany
Osteoporosis is estimated to affect 200 million women across the world. In Germany, the prevalence of this chronic disease among people aged 50 years and older is around 15%. In recent decades, several authors have analyzed the impact of osteoporosis on the risk of cognitive decline, but, most of these studies have been conducted outside Europe. The goal of the present study was to investigate the impact of osteoporosis on the risk of developing dementia in almost 60,000 patients followed for up to 20 years in more than 1,200 general practices in Germany.
26 July 2018
Driving is a complex task that involves perceptual, motor and cognitive abilities. These abilities may be affected in early Alzheimer Disease (AD) patients. Nevertheless, they continue to drive for more years than people with other dementia syndromes perhaps because of a deficit in self-awareness that prevents them from perceiving their driving difficulties and adapting accordingly. The purpose of the present pilot study was to closely examine the self-regulation behavior of older individuals with AD using a naturalistic driving approach.
16 July 2018
The celebration of JAD's 20th celebration continues this month with not one but two new publications. At AAIC 2018 in Chicago, will be presenting a special edition commemorative publication for JAD's 20th anniversary that looks back, as well as forward, to the journey that lies ahead for AD research. Discover the milestones that have led to JAD becoming a vehicle for more papers on AD than any other journal, receiving more citations than any other AD-focused journal. Read on for more details.
16 July 2018
JAD is pleased to announce that Greg Kennedy, a PhD candidate at the Centre for Human Psychopharmacology, Swinburne University of Technology, Hawthorn, Australia, has been chosen as the recipient of the 2018 Alzheimer Award.
20 June 2018
Ground-breaking new research has identified a unique combination of nutrients to slow the progression of Alzheimer’s Disease (AD), which affects over 520,000 people in the UK and represents a burden on the struggling NHS of over £26 billion per year. The 18-month study, published in the June edition of the respected Journal of Alzheimer’s Disease (JAD), examined the effect of nutritional compounds - found in common foods such as trout, broccoli, and peppers on people with the condition, and unveiled a ‘statistically significant’ find.
19 June 2018
An age group analysis of data from the ADvance trial has shown that participants over the age of 65 continue to derive the most benefit from Deep Brain Stimulation of the fornix (DBS-f), as observed in the data from the phase 2 findings (12 – 24 months) of the Phase II trial.
12 June 2018
The rate of decline in certain aspects of memory may be explained by a combination of overall physical fitness and the stiffness of the central arteries, researchers from Swinburne’s Centre for Human Psychopharmacology have found. A study to be published in the Journal of Alzheimer’s Disease considers the mechanisms underlying cognitive performance in older people living independently. Lead author, PhD candidate Greg Kennedy, says that from early adulthood, memory and other aspects of cognition slowly decline, with an increasing risk of developing into dementia in later life.
8 May 2018
Body-worn sensors used at home and in clinic by people with mild Alzheimer’s to assess walking could offer a cost-effective way to detect early disease and monitor progression of the illness. A pilot study involving Newcastle University has revealed low-cost wearable devices could improve clinical trial efficiency and encourage research investment.
1 May 2018
Journal of Alzheimer’s Disease marks its 20th anniversary with a milestone issue covering 20 years of Alzheimer's research
IOS Press is pleased to announce that 2018 marks the 20th anniversary of the Journal of Alzheimer’s Disease (JAD). One of the many events celebrating this milestone is the publication of an open access issue (JAD 62:3) looking back at 20 years of Alzheimer’s disease (AD) research, which is now available online.
24 April 2018
What if you could know that your mild cognitive impairment wouldn't progress in the next decade through the result of two simple neuropsychological tests?
Researchers from the Lisbon School of Medicine, University of Lisbon found that, in some mild cognitive impairment patients, real neuropsychological stability over a decade is possible and that long-term stability could be predicted based on neuropsychological tests measuring memory and non-verbal abstract reasoning.